Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-12

Clinical Trial Update: A Study of TRK-170 for the Treatment of Crohn's Disease [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating TRK-170 for Crohn's Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRK-170

Snippet

Sponsor: Toray Industries, Inc | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED